Traitement en cours

Veuillez attendre...

Paramétrages

Paramétrages

Aller à Demande

1. CO6541617 - MÉTODO PARA TRATAR LA INSUFICIENCIA CARDÍACA CON PÉPTIDOS TIPO ESTRESCOPINA

Office
Colombie
Numéro de la demande 12090200
Date de la demande 30.05.2012
Numéro de publication 6541617
Date de publication 16.10.2012
Type de publication A2
CIB
A61K 38/16
ANÉCESSITÉS COURANTES DE LA VIE
61SCIENCES MÉDICALE OU VÉTÉRINAIRE; HYGIÈNE
KPRÉPARATIONS À USAGE MÉDICAL, DENTAIRE OU POUR LA TOILETTE
38Préparations médicinales contenant des peptides
16Peptides ayant plus de 20 amino-acides; Gastrines; Somatostatines; Mélanotropines; Leurs dérivés
CPC
A61K 38/2228
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
22Hormones
2228Corticotropin releasing factor [CRF] (Urotensin)
A61P 3/10
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3Drugs for disorders of the metabolism
08for glucose homeostasis
10for hyperglycaemia, e.g. antidiabetics
A61P 9/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9Drugs for disorders of the cardiovascular system
A61P 9/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9Drugs for disorders of the cardiovascular system
04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Déposants JANSSEN PHARMACEUTICA N.V.
Inventeurs PETER ,GENGO
HANI N ,SABBAH
NIGEL P ,SHANKLEY
Données relatives à la priorité 12612548 04.11.2009 US
61/258.181 04.11.2009 US
Titre
(ES) MÉTODO PARA TRATAR LA INSUFICIENCIA CARDÍACA CON PÉPTIDOS TIPO ESTRESCOPINA
Abrégé
(ES)
La presente invención se relaciona con métodos nuevos para tratar la insuficiencia cardíaca; los métodos comprenden administrar una cantidad de péptido tipo estrescopina a un sujeto que lo requiere y prácticamente mantener la cantidad del péptido presente en el plasma del sujeto a una concentración que produce un beneficio terapéutico sin un incremento sustancial en la frecuencia cardíaca del sujeto. El método implica el uso de péptidos tipo estrescopina que son agonistas selectivos del receptor de la hormona de liberación de corticotropina tipo 2 (CRHR2).

Related patent documents
NI2012-000085 IThis application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
CO12090200This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
UAa201206780This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.